13F
中

NRXP NRX PHARMACEUTICALS INC

2026Q1 · CUSIP 629444209 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
31
Δ holders QoQ
+3
Breadth percentile
Top 50%
Whale holders
11
Δ whales
-1
Inst. holding value
$13M
New positions
11
Closed positions
8
Price momentum (1Q)
—
Put / Call
2/4

Breadth history (34 quarters)

2024Q3: Δ-1 · h=19 2024Q4: Δ+5 · h=24 2025Q1: Δ-1 · h=23 2025Q2: Δ+3 · h=26 2025Q3: Δ-2 · h=24 2025Q4: Δ+4 · h=28 2026Q1: Δ+3 · h=31 2024Q3: holders=19 2024Q4: holders=24 2025Q1: holders=23 2025Q2: holders=26 2025Q3: holders=24 2025Q4: holders=28 2026Q1: holders=31 -5 -2.5 +0 +2.5 +5 172533 24Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
2
QoQ: +2
Call holders
4
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.04
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2024-03-31: EPS -0.74 2024-06-30: EPS -0.75 2024-09-30: EPS -0.15 2024-12-31: EPS -0.72 2025-03-31: EPS -0.34 2025-06-30: EPS -0.98 2025-09-30: EPS -0.27 2025-12-31: EPS 0.25 2026-03-31: EPS -0.04 -1.08 -0.40 0.28 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)